PHIO Q2 2020 Earnings — Phio Pharmaceuticals Corp. Revenue & Financial Results | Market Cap Arena

PHIOPhio Pharmaceuticals Corp.

$13M

Q2 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$779,000

Operating Income

-$2M

Net Income

-$2M

EPS (Diluted)

$-36.40

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$2M

Free Cash Flow

-$2M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$20M

Total Liabilities

$2M

Stockholders' Equity

$18M

Cash & Equivalents

$19M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$779,000	-$1M	+32.0%
Operating Income	-$2M	-$2M	+18.9%
Net Income	-$2M	-$2M	+17.8%